More recently, clinical studies have identified patients with inborn activating mutations in NRF2 (NFE2L2), and these patients manifest with a multisystem disorder that involves a failure to thrive, immunodeficiency, and neurological symptoms (18). The gene discussed is NFE2L2; the disease is Failure to thrive.